Profile data is unavailable for this security.
About the company
Guangzhou LBP Medicine Science & Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. The Company’s main products are pathological diagnostic reagents and instruments, covering three major technology platforms for cytological diagnosis, molecular diagnosis and immunodiagnosis, including LBP series, IHC series, PCR series and FISH series, such as integrated slide and dyeing machine, liquid-based cell and microorganism processing, preservation reagents, automatic nucleic acid molecular hybridization instrument, automatic slide processing system and immunochromogenic reagents, etc. Its products are mainly used in pathological diagnosis of tumors. The Company operates its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)495.46m
- Net income in CNY32.09m
- Incorporated2005
- Employees907.00
- LocationGuangzhou LBP Medicine Science & Technology Co LtdNo. 2, Kexin Street, Fengxin RoadScience City, Huangpu DistrictGUANGZHOU 510663ChinaCHN
- Phone+86 2 032210051
- Fax+86 2 032290284
- Websitehttp://www.gzlbp.com/
More ▼
Mergers & acquisitions
| Acquired company | 688393:SHH since announced | Transaction value |
|---|---|---|
| Guangzhou LBP Medical Laboratory Co Ltd | 33.09% | 631.00k |
Data delayed at least 15 minutes, as of Nov 15 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Nanfang Medical Co Ltd | 584.85m | -167.99m | 1.29bn | 858.00 | -- | 2.83 | -- | 2.21 | -0.5812 | -0.5812 | 2.02 | 1.58 | 0.4294 | 1.86 | 3.49 | 681,641.10 | -12.31 | -1.09 | -28.91 | -2.00 | 5.64 | 20.14 | -28.66 | -1.91 | 0.3748 | -9.58 | 0.5314 | -- | 10.03 | 4.57 | -906.35 | -- | -3.18 | -- |
| Suzhou Iron Technology Co Ltd | 323.32m | -43.37m | 1.30bn | 680.00 | -- | 1.73 | -- | 4.01 | -0.5716 | -0.5716 | 4.24 | 9.72 | 0.2343 | 1.93 | 1.18 | 475,466.10 | -3.40 | 7.11 | -5.48 | 10.56 | 46.24 | 56.00 | -14.52 | 19.17 | 1.23 | -4.90 | 0.2571 | 25.00 | -23.84 | 8.73 | -71.17 | -10.40 | 36.50 | -- |
| CareRay Digital Medical Technology CoLtd | 287.84m | 24.70m | 1.32bn | 252.00 | 54.18 | 1.55 | -- | 4.59 | 0.2769 | 0.2769 | 3.22 | 9.69 | 0.3062 | 1.60 | 3.92 | 1,142,221.00 | 2.62 | 6.65 | 2.85 | 7.37 | 42.76 | 41.17 | 8.55 | 15.64 | 6.76 | -- | 0.0224 | 27.61 | 33.81 | 5.17 | 374.05 | -20.74 | 77.38 | -- |
| Touchstone International Medi Sci Co Ltd | 274.03m | 56.95m | 1.53bn | 243.00 | 25.73 | 2.67 | -- | 5.57 | 0.731 | 0.731 | 3.51 | 7.05 | 0.4352 | 3.16 | 18.94 | 1,127,699.00 | 9.05 | 10.09 | 10.06 | 10.82 | 55.96 | 57.59 | 20.78 | 20.17 | 4.76 | -- | 0.0028 | 24.66 | 9.31 | 16.34 | 9.53 | 15.39 | -2.39 | -- |
| Thalys Medical Technology Group Corp | 1.90bn | -210.78m | 1.65bn | 1.41k | -- | 1.55 | -- | 0.8715 | -1.36 | -1.36 | 11.68 | 5.31 | 0.5508 | 4.16 | 1.22 | 1,349,051.00 | -6.04 | -0.8933 | -11.27 | -1.62 | 18.51 | 22.12 | -10.97 | -1.49 | 1.43 | -0.9666 | 0.4974 | -- | -13.10 | 8.77 | -2.69 | -- | -19.20 | -- |
| Shanghai Rendu Biotechnology Co Ltd | 177.96m | 21.27m | 1.67bn | 358.00 | 78.73 | 1.81 | -- | 9.41 | 0.5318 | 0.5318 | 4.45 | 23.18 | 0.1734 | 1.29 | 2.41 | 497,088.50 | 2.07 | 6.26 | 2.22 | 7.17 | 79.87 | 74.36 | 11.95 | 14.54 | 12.02 | -- | 0.0052 | 7.96 | -45.89 | 18.85 | -64.60 | -- | 23.48 | -- |
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 495.46m | 32.09m | 1.89bn | 907.00 | 59.14 | 1.48 | -- | 3.81 | 0.3414 | 0.3414 | 5.21 | 13.62 | 0.3594 | 2.01 | 1.98 | 546,263.80 | 1.84 | 5.10 | 1.92 | 5.55 | 66.92 | 75.15 | 5.12 | 12.97 | 7.74 | -- | 0.0101 | 24.42 | -1.99 | 10.18 | -6.18 | -8.21 | -2.98 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 524.26m | 70.98m | 2.04bn | 1.09k | 25.92 | 1.74 | -- | 3.88 | 0.5598 | 0.5598 | 4.13 | 8.32 | 0.3246 | 3.30 | 4.08 | 480,536.10 | 4.41 | 9.35 | 4.68 | 10.39 | 37.71 | 36.76 | 13.60 | 17.89 | 7.82 | 5.33 | 0.2333 | 29.64 | -24.06 | 17.42 | -60.34 | -8.02 | 47.32 | -- |
| Allgens Medical Technology Co Ltd | 191.19m | 5.11m | 2.28bn | 202.00 | 483.35 | 1.61 | -- | 11.94 | 0.0348 | 0.0348 | 1.45 | 10.49 | 0.1251 | 1.32 | 2.81 | 946,490.30 | 0.0232 | 7.62 | 0.0241 | 8.30 | 73.87 | 83.60 | 0.1855 | 39.05 | 24.27 | -- | 0.0333 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
| Jiangsu Cowin Biotech Co Ltd | 118.17m | -144.51m | 2.47bn | 657.00 | -- | 1.61 | -- | 20.94 | -1.30 | -1.30 | 1.06 | 13.63 | 0.0667 | 1.32 | 1.43 | 179,863.40 | -8.45 | -- | -8.93 | -- | 53.54 | -- | -126.60 | -- | 13.60 | -- | 0.0214 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
Data as of Nov 15 2024. Currency figures normalised to Guangzhou LBP Medicine Science & Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2024 | 546.82k | 2.58% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 270.74k | 1.28% |
| Mercer Global Investments Europe Ltd.as of 31 Dec 2023 | 89.45k | 0.42% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2024 | 86.20k | 0.41% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 64.38k | 0.30% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 43.25k | 0.20% |
| Springs Fund Management Co. Ltd.as of 30 Jun 2024 | 34.20k | 0.16% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 30.53k | 0.14% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 24.40k | 0.12% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 22.44k | 0.11% |
More ▼
Data from 28 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
